General Information


DRACP ID  DRACP04080

Peptide Name  

Sequence  CASYFC

Sequence Length  6

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C30H40N6O9S2

Absent amino acids  DEGHIKLMNPQRTVW

Common amino acids  C

Mass  78217

Pl  5.81

Basic residues  0

Acidic residues  0

Hydrophobic residues  2

Net charge  0

Boman Index  381

Hydrophobicity  125

Aliphatic Index  16.67

Half Life 
  Mammalian: 1.2 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  1615

Absorbance 280nm  323

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 33042031

Title  Hybrid Antimicrobial Peptide Targeting Staphylococcus aureu s and Displaying Anti-infective Activity in a Murine Model

Doi Not available

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  16903

DRACP is developed by Dr.Zheng's team.